As per DelveInsight Business Research LLP, the Acute Kidney Injury Market size in the 7 MM was observed to be USD 4,082.95 Million in 2017.
The United States accounted for the maximum Acute Kidney Injury cases among 7MM countries with an incidence of 895,078 in 2017. On the other hand, Japan accounted for the least share of Acute Kidney Injury Incidence.
Emerging therapies in the Acute kidney injury pipeline look promising as several companies such as Angion, Atox Bio, Exponential Biotherapies, Inc., Orion Pharma Ltd, Astellas Pharma US, MediBeacon Inc., AM-Pharma, Quark Pharma, and Pharming Technologies are proactively looking to foster the Acute kidney injury market through their novel molecules and R&D.
For more details visit: https://www.delveinsight.com/blog/acute-kidney-injury-market/